TABLE 2

Pharmacological and non-pharmacological treatment for patients with relapsing polychondritis

PatientSexAge yearsCPAPStentIS drugsCorticosteroid dosePrevious drugsBaseline RPDAI
1M65NNMTXPred37
2F70NNMMF, infliximabPred 5 mgSSZ27
3F50DNTNMTXPred45
4F53YYMMF, MTXPred 10 mgAZA, cyclophosphamide, ADA and ETN47
5F76YNSSZ, HCQ, ABT, IVIGPred 7.5 mgMTX, ETN, leflunomide, AZA44
6F74YYMTX, AZAPred 10 mgCyclophosphamide43
7F76YNCyclophosphamidePred 10 mgMTX27
8F70NNAZAPred 5 mg15
9F78DNTNPred 5 mgMTX, AZA, HCQ24
10M31NNHCT 20/10/1033
11F52NNSecukinumabPred 10 mgMTX, ETN, HCQ, cyclophosphamide, ADA38
12M79NNPred 5 mg35
13M78YYMTXPred 5 mgAZA40

CPAP: continuous positive airway pressure; IS: immunosuppressant; RPDAI: Relapsing Polychondritis Activity Index; MTX: methotrexate; Pred: prednisolone; MMF: mycophenolate mofetil; SSZ: sulfasalazine; DNT: did not tolerate; AZA: azathioprine; ETN: etanercept; HCQ: hydroxychloroquine; ABT: abatacept; IVIG: intravenous immunoglobulin; HCT: hydrocortisone; ADA: adalimumab.